AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitabees-M 500 Tablet

Prescription Icon
Prescription Required

Marketer

Amcare Pharmaceuticals

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitabees-M 500 Tablet

Diabexe-Duo 500mg tablets combine two medications to effectively manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent serious diabetic complications like kidney failure and vision loss, potentially lowering the risk of cardiovascular events. Diabexe-Duo 500mg may be prescribed as monotherapy or in conjunction with other antidiabetic agents. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, blood glucose levels, and other medications. Taking it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under physician guidance. Adherence to the prescribed diet and exercise regimen is crucial. Lifestyle choices are integral to diabetes management. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; understanding its recognition and management is essential. This medication is not universally suitable. Prior to commencing treatment, inform your doctor of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating women should seek medical advice before use. Potential drug interactions exist; disclose all medications to ensure safety. Alcohol should be limited due to its potential to exacerbate hypoglycemia. Your physician will monitor renal function and blood glucose levels throughout treatment.

Primary Ingredients of Sitabees-M 500 Tablet

No text provided. Please provide the text you would like me to rephrase.

Uses of Sitabees-M 500 Tablet

Managing type 2 diabetes

Major Benefits of Sitabees-M 500 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sitabees-M 500mg tablets should be administered with food.

Common Side effects of Sitabees-M 500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitabees-M 500 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sitabees-M 500mg tablets should be administered with a meal.

How Sitabees-M 500 Tablet works:

Sitabees-M 500 Tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This combined action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitabees-M 500 Tablet and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitabees-M 500 Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitabees-M 500 Tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Sitabees-M 500 Tablets cautiously, potentially requiring dose modification. Severe kidney disease contraindicates Sitabees-M 500 Tablet use. Physician consultation is recommended. Regular monitoring of kidney function is advised during treatment.

LiverLiverUNSAFE

The use of Sitabees-M 500 Tablets is potentially hazardous for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitabees-M 500 Tablet :

Should you forget a dose of Sitabees-M 500 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitabees-M 500 Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Sitabees-M 500 Tablet

The medication Sitabees-M 500 Tablet combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This treatment enhances blood sugar control when coupled with a suitable diet and physical activity. Metformin reduces hepatic glucose production and improves insulin responsiveness. Sitagliptin blocks DPP-4, boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Prolonged Sitabees-M 500 Tablet consumption can indeed lead to Vitamin B12 deficiency. This medication impairs Vitamin B12 absorption in the gastrointestinal tract. Untreated deficiency may result in anemia and neurological complications, manifesting as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures, according to some studies, include annual supplemental Vitamin B12 intake.
Sitabees-M 500 Tablet may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious side effects such as lactic acidosis may also occur. Prolonged use can result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitabees-M 500 Tablet constituents or inactive ingredients should not take this medication. Its use is contraindicated in individuals with severely compromised kidney or liver function, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitabees-M 500 Tablet with alcohol is unsafe due to a heightened risk of lactic acidosis.
Always keep this medication in its original, tightly sealed container. Follow the storage instructions provided on the packaging. Discard any leftover medication. Prevent access by children, pets, and others.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential consequence of Sitabees-M 500 Tablet use. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse reaction necessitates caution, particularly for individuals with pre-existing kidney impairment, advanced age, or significant alcohol consumption. Symptoms may manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia. The appearance of these symptoms warrants immediate cessation of Sitagliptin + Metformin and prompt medical attention.
Sitabees-M 500 Tablet combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This medication helps regulate blood sugar when used with a balanced diet and regular physical activity. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin blocks DPP4, boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitabees-M 500 Tablet may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious side effects such as lactic acidosis may also occur. Prolonged use can result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitabees-M 500 Tablet constituents or inactive ingredients should not use this medication. Similarly, its use is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitabees-M 500 Tablet and alcohol is unsafe due to a heightened risk of lactic acidosis.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential complication of Sitabees-M 500 Tablet use. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse effect necessitates caution in individuals with pre-existing kidney impairment, advanced age, or significant alcohol consumption. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. The appearance of any of these symptoms warrants immediate cessation of Sitagliptin + Metformin and prompt medical attention.
Prolonged Sitabees-M 500 Tablet use can indeed lead to vitamin B12 deficiency by hindering its gastrointestinal absorption. This deficiency, if left unaddressed, may result in anemia and neurological complications. Symptoms can include paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, supplemental vitamin B12 is recommended annually by some experts.
Maintain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and others.
The medication Sitabees-M 500 Tablet combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This treatment enhances blood sugar control when paired with a suitable diet and consistent physical activity. Metformin reduces hepatic glucose production and improves insulin responsiveness. Sitagliptin's mechanism involves DPP4 enzyme inhibition, boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitabees-M 500 Tablet may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious adverse reactions such as lactic acidosis can occur. Prolonged use might result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitabees-M 500 Tablet constituents or inactive ingredients should not use this medication. Similarly, its use is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitabees-M 500 Tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential adverse effect of Sitabees-M 500 Tablet. Also termed Metformin-associated lactic acidosis (MALA), this rare complication necessitates caution in patients with impaired kidney function, advanced age, or significant alcohol consumption. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms appear, discontinue Sitabees-M 500 Tablet and seek immediate medical attention.
Prolonged Sitabees-M 500 Tablet use can indeed lead to vitamin B12 deficiency by hindering its absorption in the gastrointestinal tract. This deficiency, if left unaddressed, may result in anemia and neurological complications. These complications can manifest as numbness and tingling in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and impaired coordination. To mitigate these risks, supplemental vitamin B12 intake, at least annually, has been proposed by some studies.
Retain this medication within its original, securely sealed container. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and other individuals.
Sitabees-M 500 Tablet
177
MRP 205
13% off